Our education specialists are working on the new Interdisciplinary Biomedical Research Building at the University of Warwick, which is being completed to world-class, industry leading standards as 50% is going to be pre-manufactured value (PMV).

The £33m state-of-the-art research building on the University’s Gibbet Hill campus – which will be built using a PMV pre cast concrete frame - will bring together up to 300 biomedical researchers to fight human diseases. The new building is 7000sq meters and will provide a 400-seat lecture theatre and a five-storey laboratory as well as various social and collaboration spaces.

Nick Preedy, construction manager at Willmott Dixon, said:

“This is a hugely important scheme for the University and we are proud to be part of its creation – this project continues our pre-standing relationship with the University which recently saw us complete its new £33m Sports and Wellness Hub.

This a really exciting project to be a part of, not only will the research that takes place in the building be revolutionary, but the construction process itself is something really special. With over half of the project being manufactured off-site, we are able to cut the build time down to just 87 weeks.

Using PMV not only has a positive impact on the sustainability, logistics and carbon footprint of the build but the factory build environments also provide better quality control, less strain on specialist trades on site and less site deliveries. This in turn benefits the local community by ensuring the local roads of Coventry and the University are much quieter.”

Professor Sudhesh Kumar, dean of the Warwick Medical School said:

“We are very excited about the development of the new IBRB building on the Gibbet Hill site. It forms an integral element of the Medical School’s ambitions over the coming years. The inclusion of a brand new lecture theatre will enhance student experience and enable growth of new undergraduate programmes. The excellent research facilities within the building will foster inter-disciplinary collaboration and enable biomedical research at the highest level.”

The project is due to be completed by the end of 2020.